Drug Shortage Report for AZITHROMYCIN FOR INJECTION USP
Report ID | 111093 |
Drug Identification Number | 02483890 |
Brand name | AZITHROMYCIN FOR INJECTION USP |
Common or Proper name | AZYTHROMYCIN FOR INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-03-30 |
Estimated end date | |
Actual end date | 2020-04-07 |
Shortage status | Resolved |
Updated date | 2020-04-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-04-07 | French | Compare |
v3 | 2020-04-07 | English | Compare |
v2 | 2020-04-06 | French | Compare |
v1 | 2020-04-06 | English | Compare |
Showing 1 to 4 of 4